The overexpression of many MMP family members, such as MMP1, MMP2, MMP7, MMP9, and MMP11 has been found to be involved in cancer progression [33, 35, 36]; therefore, the development of MMP inhibitors has become an effective strategy in clinical cancer therapies [37]. This evidence concerns the gene MMP2 and cancer.